Saving lives, spending less: the case for investing in noncommunicable diseases: methods supplement

Overview

The analytic scope for this report closely follows that of the original NCD Global Business Plan, published in 2018, including the interventions analyzed, the country inclusion criteria, and the overall methodological structure. This report focuses on the 16 “best buys” for NCDs as described in the Appendix 3 of the Global Action Plan for NCDs, updated in 20172 (Table 1). The NCD Best Buys are a set of evidence-based priority interventions for NCD prevention and control, which include considerations of cost-effectiveness, feasibility, affordability, acceptability, and potential for successful implementation. While some recent studies may support the cost-effectiveness of other interventions for NCDs, this analysis currently only includes the 16 most cost-effective interventions as endorsed by the World Health Assembly.